The Technical Scientific Commission (CTS) of AIFA, in the extraordinary session of 5 January 2022, at the request of the Ministry of Health, expressed its favorable opinion on the possibility of providing a vaccine booster dose also for subjects aged 12 and 15 years.
In analogy with what has already been established for the age group 16-17 years and for frail subjects of 12-15 years, this booster must be carried out with the Comirnaty vaccine.